Скачать
Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer
Автор: Breast Cancers Today
Загружено: 2025-04-22
Просмотров: 141
Описание:
Dr. Sara Nunnery, director of breast cancer research at Tennessee Oncology, discusses the evolving classification of HER2-low and HER2-ultralow breast cancer, and the clinical implications of the DESTINY-Breast06 trial. She explains how precise pathology reporting is key to identifying eligible patients and offers insights into how Enhertu (trastuzumab deruxtecan) is changing treatment decisions in HR-positive, HER2-low metastatic breast cancer.
#breastcancer #her2 #enhertu #oncology #cancerresearch #medtwitter
Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
